Israel
· Delayed Price · Currency is ILS · Price in ILA BrainsWay Statistics
Total Valuation
BrainsWay has a market cap or net worth of ILS 801.90 million. The enterprise value is 556.01 million.
| Market Cap | 801.90M |
| Enterprise Value | 556.01M |
Important Dates
The next estimated earnings date is Wednesday, August 13, 2025.
| Earnings Date | Aug 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
BrainsWay has 37.79 million shares outstanding.
| Current Share Class | 37.79M |
| Shares Outstanding | 37.79M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +43.02% |
| Owned by Insiders (%) | 19.61% |
| Owned by Institutions (%) | 22.27% |
| Float | 24.17M |
Valuation Ratios
The trailing PE ratio is 71.99 and the forward PE ratio is 43.05.
| PE Ratio | 71.99 |
| Forward PE | 43.05 |
| PS Ratio | 4.96 |
| PB Ratio | 3.38 |
| P/TBV Ratio | 3.38 |
| P/FCF Ratio | 26.86 |
| P/OCF Ratio | 17.75 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 40.12, with an EV/FCF ratio of 18.63.
| EV / Earnings | 38.12 |
| EV / Sales | 3.44 |
| EV / EBITDA | 40.12 |
| EV / EBIT | 79.68 |
| EV / FCF | 18.63 |
Financial Position
The company has a current ratio of 5.03, with a Debt / Equity ratio of 0.09.
| Current Ratio | 5.03 |
| Quick Ratio | 4.66 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | 1.50 |
| Debt / FCF | 0.69 |
| Interest Coverage | 1.33 |
Financial Efficiency
Return on equity (ROE) is 7.41% and return on invested capital (ROIC) is 2.10%.
| Return on Equity (ROE) | 7.41% |
| Return on Assets (ROA) | 1.42% |
| Return on Invested Capital (ROIC) | 2.10% |
| Return on Capital Employed (ROCE) | 2.25% |
| Revenue Per Employee | 1.35M |
| Profits Per Employee | 121,541 |
| Employee Count | 120 |
| Asset Turnover | 0.53 |
| Inventory Turnover | 2.60 |
Taxes
In the past 12 months, BrainsWay has paid 1.95 million in taxes.
| Income Tax | 1.95M |
| Effective Tax Rate | 11.78% |
Stock Price Statistics
The stock price has increased by +79.83% in the last 52 weeks. The beta is 0.25, so BrainsWay's price volatility has been lower than the market average.
| Beta (5Y) | 0.25 |
| 52-Week Price Change | +79.83% |
| 50-Day Moving Average | 1,783.08 |
| 200-Day Moving Average | 1,808.44 |
| Relative Strength Index (RSI) | 67.88 |
| Average Volume (20 Days) | 82,650 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BrainsWay had revenue of ILS 161.81 million and earned 14.58 million in profits. Earnings per share was 0.29.
| Revenue | 161.81M |
| Gross Profit | 120.56M |
| Operating Income | 6.98M |
| Pretax Income | 16.53M |
| Net Income | 14.58M |
| EBITDA | 12.06M |
| EBIT | 6.98M |
| Earnings Per Share (EPS) | 0.29 |
Balance Sheet
The company has 266.61 million in cash and 20.72 million in debt, giving a net cash position of 245.89 million or 6.51 per share.
| Cash & Cash Equivalents | 266.61M |
| Total Debt | 20.72M |
| Net Cash | 245.89M |
| Net Cash Per Share | 6.51 |
| Equity (Book Value) | 237.37M |
| Book Value Per Share | 6.43 |
| Working Capital | 252.49M |
Cash Flow
In the last 12 months, operating cash flow was 45.17 million and capital expenditures -15.31 million, giving a free cash flow of 29.85 million.
| Operating Cash Flow | 45.17M |
| Capital Expenditures | -15.31M |
| Free Cash Flow | 29.85M |
| FCF Per Share | 0.79 |
Margins
Gross margin is 74.51%, with operating and profit margins of 4.31% and 9.01%.
| Gross Margin | 74.51% |
| Operating Margin | 4.31% |
| Pretax Margin | 10.22% |
| Profit Margin | 9.01% |
| EBITDA Margin | 7.45% |
| EBIT Margin | 4.31% |
| FCF Margin | 18.45% |
Dividends & Yields
BrainsWay does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | 1.82% |
| FCF Yield | 3.72% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on May 22, 2011. It was a reverse split with a ratio of 0.25.
| Last Split Date | May 22, 2011 |
| Split Type | Reverse |
| Split Ratio | 0.25 |
Scores
BrainsWay has an Altman Z-Score of 2.37 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.37 |
| Piotroski F-Score | 6 |